BerganKDV Wealth Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$39.1K Sell
203
-22
-10% -$4.37K ﹤0.01% 406
2023
Q1
$45.6K Buy
225
+3
+1% +$481 ﹤0.01% 402
2022
Q4
$28.5K Sell
222
-1
-0.4% -$129 ﹤0.01% 449
2022
Q3
$31K Sell
223
-48
-18% -$7.82K ﹤0.01% 430
2022
Q2
$48K Hold
271
0.01% 389
2022
Q1
$39K Buy
271
+195
+257% +$26.4K ﹤0.01% 423
2021
Q4
$12K Sell
76
-199
-72% -$33.3K ﹤0.01% 638
2021
Q3
$47K Hold
275
0.01% 412
2021
Q2
$43K Hold
275
0.01% 413
2021
Q1
$38K Hold
275
﹤0.01% 402
2020
Q4
$48K Buy
275
+31
+13% +$5.78K 0.01% 357
2020
Q3
$48K Buy
244
+5
+2% +$837 0.01% 341
2020
Q2
$41K Buy
239
+213
+819% +$31.8K 0.01% 374
2020
Q1
$3K Hold
26
﹤0.01% 702
2019
Q4
$3K Buy
+26
New +$2.76K ﹤0.01% 732

Other funds holding SGEN

BerganKDV Wealth Management's SGEN Position: Q2 2023 in Review

BerganKDV Wealth Management reduced its Seagen Inc. Common Stock (SGEN) stake by 9.8% in Q2 2023, selling an estimated $4.37K and leaving 203 shares worth $39.1K. The position accounts for ﹤0.01% of the portfolio, ranked #406.

BerganKDV Wealth Management first reported a position in SGEN in Q4 2019 and has held it in 15 quarters since. The position peaked at $48K in Q2 2022. 594 funds tracked by Wall St. Rank hold SGEN as of Q2 2023.

  • BerganKDV Wealth Management held 203 shares of Seagen Inc. Common Stock worth $39.1K as of Q2 2023.
  • BerganKDV Wealth Management sold 22 Seagen Inc. Common Stock shares in Q2 2023, an estimated $4.37K.
  • Seagen Inc. Common Stock made up ﹤0.01% of BerganKDV Wealth Management's portfolio in Q2 2023, its #406 holding.
  • BerganKDV Wealth Management first reported a position in Seagen Inc. Common Stock in Q4 2019 and has held it in 15 quarters since.
  • BerganKDV Wealth Management's Seagen Inc. Common Stock position peaked at $48K in Q2 2022.
  • 594 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.